The levels of soluble BMP2 and BMP4 were significantly increased in AML patients compared to healthy donors by 2.9-fold (P = 0.0100) and 3.6-fold (P < 0.0001), respectively (Fig. 1a). The gene discussed is BMP4; the disease is acute myeloid leukemia.